Company news
Avacta Group PLC news in 2025
Avacta Group PLC's news releases, calls and decks from 2025, newest first.
Avacta to Present at Leerink Healthcare Conference
March 10, 2025
Avacta Therapeutics to Present at the 2025 Leerink Global Healthcare Conference
March 10, 2025
Avacta Announces Promising Early Efficacy and Safety Data for AVA6000 in the Phase 1a Dose Escalation and Ongoing Enrollment in the Phase 1b Expansion Cohorts
March 7, 2025
Avacta announces data update for AVA6000
March 7, 2025
Avacta to sell Launch Diagnostics
March 7, 2025
Appointment of Joint Broker
February 4, 2025
Avacta Announces Data from AVA6000 Phase 1 trial
January 16, 2025
Avacta Appoints Chief Financial Officer
January 13, 2025
Calls in 2025
- Avacta Group (LSE:AVCT) — Phase 1b Faridoxorubicin (AVA6000) Salivary Gland Cancer Data Release
Dec 17, 2025
Transcript - Avacta Group (LSE:AVCT) Q2 2025 Earnings Call
Sep 30, 2025
Transcript - Avacta Group (LSE:AVCT) Q4 2024 Earnings Call
Jun 6, 2025
Transcript - Avacta Group (LSE:AVCT) — Preliminary Results
Jun 6, 2025
Transcript
Decks in 2025
- Q2 2025 Earnings Presentation
Earnings · 9 slides · Sep 30, 2025
- Shareholder Meeting (July 2025)
Shareholder meeting · 18 slides · Jul 2, 2025
- Investor Presentation (March 2025)
Investor deck · 28 slides · March 2025